Christensen, O. & Christensen, E. (1988) Fat consumption and schizophrenia. Acta Psychiatrica Scandinavica, 78, 587–591.
De Fronzo, R. A. & Ferrannini, E. (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173–194.
Durany, N., Michell, T., Zochling, R., et al (2001) Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenia. Schizophrenia Research, 52, 89–86.
Hansen, B. C. (1999) The metabolic syndrome X. Annals of the New York Academy of Science, 892, 1–24.
Hibbeln, J. (1998) Fish consumption and major depression (letter). Lancet, 351, 1213.
Hibbeln, J. R. & Salem, N. Jr. (1995) Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. American Journal of Clinical Nutrition, 62, 1–9.
Hopper, K. & Wanderling, J. (2000) Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISOS, the WHO collaborative follow-up project. Schizophrenia Bulletin, 26, 835–846.
Jablensky, A., Sartorius, N., Emberg, G., et al (1992) Schizophrenia: manifestations, incidence and course in different cultures: a World Health Organization 10-country study. Psychological Medicine, Monograph Supplement, 20, 1–97.
Kyriaki, G. (2003) Brain insulin: regulation, mechanisms of action and functions. Cellular and Molecular Neurobiology, 23, 1–25.
Ludwig, D. S. (2002) The Glycaemic Index. Physiological mechanisms relating to obesity, diabetes and cardiovascular disease. JAMA, 287, 2414–2423.
Mann, J. I. (2002) Diet and risk of coronary heart disease and type 2 diabetes. Lancet, 360, 783–789.
Meiers, R. L. (1973) Relative hypoglycaemia in schizophrenia. In Orthomolecular Psychiatry (eds Hawkings, D. & Pauling, L.), pp. 452–462. San Francisco, CA: W H. Freeman.
Molteni, R., Barnard, R. J., Ying, Z., et al (2002) A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience, 112, 803–814.
Nemets, B., Stahl, Z. & Belmaker, R. H. (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. American Journal of Psychiatry, 159, 477–479.
Peet, M. & Edwards, Rh. W. (1997) Lipids, depression and physical diseases. Current Opinion in Psychiatry, 10, 477–480.
Peet, M. & Horrobin, D. F. (2002) A dose-ranging study of ethyleicosapentaenoic acid in patients with ongoing depression despite apparently adequate treatment with standard drugs. Archives of General Psychiatry, 59, 913–919.
Ryan, M. C. & Thakore, J. H. (2002) Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sciences, 71, 239–257.
Summers, L. K., Fielding, B. A., Bradshaw, H. A., et al (2002) Substituting dietary fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia, 45, 369–377.
Tucker, K. L. & Buranapin, S. (2001) Nutrition and aging in developing countries. Journal of Nutrition, 131, 2417S–2423S.
Weissman, M. M., Bland, R. C., Canino, C. J., et al (1996) Cross-national epidemiology of major depression and bipolar disorder. JAMA, 276, 293–299.
Westover, A. N. & Marangell, L. B. (2002) Across-national relationship between sugar consumption and major depression. Depression and Anxiety, 16, 118–130.
World Health Organization (1979) Schizophrenia: an International Follow-up Study. New York: John Wiley.